EASL Recommendations on Treatment of Hepatitis C 2016

The European Association for the Study of the Liver (EASL) issues Recommendations on Treatment of Hepatitits C 2016:

The recommendations have been prepared by a panel of experts chosen by the EASL Governing Board and were approved by the EASL Governing Board.
They have been based as far as possible on evidence from existing publications and presentations at international meetings, and, if evidence was unavailable, the experts’ personal experiences and opinion.

These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.